Literature DB >> 330352

Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.

M C Bateson, P E Ross, J Murison, I A Bouchier.   

Abstract

Nineteen patients who received chenodeoxycholic acid 750 mg/day for six months had duodenal bile aspirated before and after treatment. In five patients with hypertriglyceridaemia but no gallstones cholesterol saturation was reversed in every case, the mean cholesterol saturation index (SI +/- standard deviation) changing from 1-38 +/- 0-31 to 0-68 +/- 0-06 (P less than 0-005). In 14 patients with gallstones there was also an improvement in bile cholesterol content, but this was not sufficient to produce mean unsaturation, saturation index changing from 1-55 +/- 0-52 to 1-13 +/- 0-43 (P less than 0-05). Only seven of 14 patients with gallstone achieved cholesterol unsaturation. In four patients with hypertriglyceridaemia and gallstones, mean unsaturation was produced and the saturation index changed from 1-70 +/- 0-45 to 0-86 +/- 0-47 (P less than 0-05). When all nine patients with hypertriglyceridaemia were grouped, the mean saturation index fell from 1-52 +/- 0-40 to 0-76 +/- 0-30 after therapy (P less than 0-001). In contrast the 10 patients without hypertriglyceridaemia showed no significant fall in saturation index which was 1-50 +/- 0-54 before and 1-24 +/- 0-40 after therapy. The ability of chenodeoxycholic acid feeding to improve bile saturation with cholesterol correlated with the presence of hypertriglyceridaemia whether or not gallstones were present. It did not correlate with gallstone dissolution or body weight.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330352      PMCID: PMC1411715          DOI: 10.1136/gut.18.8.599

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  On the lipid constituents of bile from human gallbladder containing cholesterol gallstones; a comparison with normal human bladder bile.

Authors:  B ISAKSSON
Journal:  Acta Soc Med Ups       Date:  1954-09-30

2.  It's time to be practical.

Authors:  D S Fredrickson
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

3.  The estimation of phospholipids in bile.

Authors:  J Murison; D Festi; P E Ross; I A Bouchier
Journal:  Clin Chim Acta       Date:  1976-04-15       Impact factor: 3.786

4.  Biliary lipid secretion in gallstone patients.

Authors:  T C Northfield; A F Hofmann
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

5.  Correlating metabolism of plasma and tissue cholesterol with that of plasma-lipoproteins.

Authors:  H S Sodhi; B J Kudchodkar
Journal:  Lancet       Date:  1973-03-10       Impact factor: 79.321

6.  Biliary lipid composition in normalipidemic and prebeta hyperlipoproteinemic gallstone patients. Influence of sucrose feeding of the patients on the biliary lipid composition.

Authors:  E Cahlin; J Jönsson; S Nilsson; T Scherstén
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

7.  Proceedings: The effects of different doses of chenodeoxycholic acid and of withdrawing treatment on bile lipid composition and liver function in patients with gallstones.

Authors:  H Y Mok; G D Bell; R H Dowling
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

8.  Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.

Authors:  S M Grundy
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

9.  Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects.

Authors:  B Angelin; K Einarsson; K Hellström
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

View more
  9 in total

1.  Clofibrate therapy and gallstone induction.

Authors:  M C Bateson; D Maclean; P E Ross; I A Bouchier
Journal:  Am J Dig Dis       Date:  1978-07

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  Probucol and hypercholesterolaemia.

Authors:  M C Bateson; A M Fiabane; A Clarke; I A Bouchier
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

4.  Cholesterol absorption by the gall bladder.

Authors:  P E Ross; A N Butt; C Gallacher
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

5.  Gallstones and cholecystectomy in modern Britain.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

Review 6.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

7.  Characteristics of cholesterol absorption by human gall bladder: relevance to cholesterolosis.

Authors:  M R Jacyna; P E Ross; M A Bakar; D Hopwood; I A Bouchier
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

8.  Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.

Authors:  M C Bateson; P E Ross; J Murison; J H Saunders; I A Bouchier
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

9.  Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.

Authors:  M C Bateson; P E Ross; J Murison; I A Bouchier
Journal:  Br Med J       Date:  1978-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.